Anthropic Said to Launch IPO Roadshow Tuesday, Seeking $75–100 Billion

  • Dispatched: Nov 9, 2026 · 21:38 ET (Nov 10, 02:38 UTC)

One-sentence summary: IFR, citing people familiar with the matter, reports Anthropic plans to formally launch its Nasdaq IPO roadshow on Tuesday morning, November 10, 2026 ET, with a 22-bank syndicate already holding the schedule and a target raise of $75–100 billion that would match or break the largest IPO on record; pricing and listing are expected next week.

Verification status: ⚠ IFR report citing people familiar with the matter (not yet confirmed by the company); The Wall Street Journal separately reported the same day that a debut on November 19–20 is targeted, with a filing setting out the valuation range expected early this week. The company has not commented, and the size and price range in its registration statement remain blank.

Core Facts & Consensus Delta:

Anthropic publicly filed its Form S-1 on October 26, 2026 and an amendment (S-1/A) on November 2, seeking to list Class A shares on the Nasdaq Global Select Market under the ticker ANT. Under the SEC's 15-day rule, the roadshow could begin at the earliest on November 10. IFR reported (published 2026-11-09 15:22 ET / 20:22 UTC) that the 22-bank underwriting syndicate has received the roadshow schedule, led by Goldman Sachs and Morgan Stanley; multiple relays say pricing is expected after the U.S. market close on November 18, 2026 ET, with trading to begin on November 19, while The Wall Street Journal cites November 19–20. On the SEC calendar (closed November 11 for Veterans Day, with two business days' notice required before effectiveness), the earliest possible pricing date is November 13 and the earliest first trade is November 16, so the reported November 18–19 dates fall after the earliest window.

Quantitative reference: a $75 billion raise would match SpaceX's record $75 billion IPO of June 2026, while $100 billion would exceed that record by about 33%. Valuation discussions have fallen from about $2 trillion in early October to $1.1–1.75 trillion (Reuters, November 5: buyers discussing $1.2–1.3 trillion, some as low as $1.1 trillion; Financial Times: $1.25–1.75 trillion), with a target of about $1.5 trillion — roughly 55% above the $965 billion private valuation of May 2026. On a $1.5 trillion valuation and the $87.5 billion midpoint raise, the free float would be about 5.8%. Financially, revenue was $19.7 billion for the 12 months ended June 30, 2026, and $33.2 billion for the first nine months of 2026 (up about 1,206% year over year), with third-quarter revenue of about $16.8–17.0 billion (up about 45% quarter over quarter); a $1.5 trillion valuation implies a price-to-sales ratio of about 76x on the $19.7 billion trailing revenue. Disclosed compute purchase and lease commitments total about $895.4 billion, of which $69.8 billion falls due within the next 12 months, so a $75–100 billion raise covers only about 8%–11% of that commitment total.

Supply-Chain & Market Read-Through: The report is the first concrete sign of progress since Reuters reported on November 5 that investors doubted the roadshow could start in the week of November 9 with a November listing still possible — indicating the issuance window has not slipped despite last week's technology sell-off. The direct transmission runs through the compute chain: Anthropic's commitments lean heavily on hyperscaler and Neocloud GPU/TPU supply, including a five-year master lease with Broadcom (about $125.2 billion in rent) disclosed in the S-1, so the roadshow's pricing outcome will serve as a public pricing anchor for institutional appetite toward AI compute capital spending. For HBM and memory manufacturers (SK hynix 000660.KS, Samsung Electronics 005930.KS, Micron MU, SanDisk SNDK), the financing outcome of a leading AI lab and the pace of its subsequent compute procurement directly affect HBM3E/HBM4 order visibility and the negotiating position for 2027–2028 capacity lock-ins; the raise itself, however, does not translate one-for-one into new compute orders, which must be verified in the pricing filing and later procurement disclosures. The timing follows the November 9 launch of Claude Fable 5.2 and Mythos 5.2 (API prices cut 20%, output speed up as much as 30%), suggesting the company used a product launch the day before the roadshow to reinforce its commercialization narrative.

Next Catalysts & Watchpoints:

  • Tuesday morning, 2026-11-10 ET (exact time undisclosed): whether the roadshow starts as reported and whether the company issues an official statement.
  • Early this week (ET): whether the valuation range, share count and raise are submitted via an S-1/A amendment, and whether the range falls within the reported $1.1–1.75 trillion.
  • Around 2026-11-18 16:00 ET / 21:00 UTC: whether pricing is set after the close as reported; 2026-11-19–20: whether the shares debut on Nasdaq (ticker ANT) as scheduled, with first-day trading set to become a public reference point for AI asset pricing.

Sources:

Information only, not investment advice.

→ 阅读中文版

More flash alerts from 2026-11-09

INSTANT ARCHIVE SEARCH

Search Stocks, Earnings & Macro Alerts

Quick tags: